US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US6713061B1
(en)
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
WO1997033904A1
(en)
|
1996-03-12 |
1997-09-18 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US7357927B2
(en)
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
US6455040B1
(en)
*
|
1997-01-14 |
2002-09-24 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptor 5
|
EP0857782A3
(en)
*
|
1997-01-27 |
1999-12-22 |
Smithkline Beecham Corporation |
Novel mammalian DD-1 gene
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US7452538B2
(en)
*
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US6433147B1
(en)
*
|
1997-01-28 |
2002-08-13 |
Human Genome Sciences, Inc. |
Death domain containing receptor-4
|
ES2284199T5
(es)
*
|
1997-01-28 |
2011-11-14 |
Human Genome Sciences, Inc. |
Receptor 4 que contiene dominio de muerte (dr4: receptor 4 de muerte), miembro de la superfamilia de receptores de tnf y unión a trail (apo-2l).
|
US7528239B1
(en)
|
1997-02-13 |
2009-05-05 |
Immunex Corporation |
Receptor that binds trail
|
US6072047A
(en)
|
1997-02-13 |
2000-06-06 |
Immunex Corporation |
Receptor that binds trail
|
US20050233958A1
(en)
*
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20040136951A1
(en)
*
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US20080248046A1
(en)
*
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
US6872568B1
(en)
*
|
1997-03-17 |
2005-03-29 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5 antibodies
|
PT970213E
(pt)
*
|
1997-03-17 |
2007-04-30 |
Human Genome Sciences Inc |
Receptor 5 contendo um domínio de morte
|
US6214580B1
(en)
|
1997-05-30 |
2001-04-10 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
US6506569B1
(en)
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
ATE393222T1
(de)
|
1997-09-18 |
2008-05-15 |
Genentech Inc |
Dcr3 polypeptid, ein tnfr homolog
|
US20040180049A1
(en)
*
|
1998-01-26 |
2004-09-16 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
AU2007200507B2
(en)
*
|
1998-01-26 |
2010-03-11 |
Genentech, Inc. |
Antibodies to death receptor 4 (DR4) and uses thereof
|
AU2338299A
(en)
|
1998-01-26 |
1999-08-09 |
Genentech Inc. |
Antibodies to death receptor 4 (dr4) and uses thereof
|
US20040120947A1
(en)
*
|
1998-01-26 |
2004-06-24 |
Genentech, Inc. |
DR4 antibodies and uses thereof
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
WO2000050620A2
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
CA2371114A1
(en)
*
|
1999-04-22 |
2000-11-02 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
CA2373063A1
(en)
*
|
1999-05-06 |
2000-11-16 |
Jian Ni |
Death domain containing receptor 4
|
PT1181319E
(pt)
*
|
1999-05-28 |
2009-07-14 |
Genentech Inc |
Anticorpos quiméricos contra dr4 e suas utilizações
|
WO2001014542A1
(en)
*
|
1999-08-25 |
2001-03-01 |
Genome Therapeutics Corporation |
A transmembrane trap for isolating membrane bound proteins
|
ATE329610T1
(de)
|
2000-02-16 |
2006-07-15 |
Genentech Inc |
Anti-april antikörper und hybridomazellen
|
EP1272647B1
(en)
|
2000-04-11 |
2014-11-12 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
CA2405557C
(en)
|
2000-04-12 |
2013-09-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7279160B2
(en)
*
|
2000-05-02 |
2007-10-09 |
The Uab Research Foundation |
Combinations of DR5 antibodies and other therapeutic agents
|
TWI318983B
(en)
*
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
US7476383B2
(en)
|
2000-05-02 |
2009-01-13 |
The Uab Research Foundation |
Antibody selective for DR4 and uses thereof
|
WO2001096528A2
(en)
|
2000-06-15 |
2001-12-20 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
AU2001268427B2
(en)
|
2000-06-16 |
2007-03-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to blys
|
DE60136816D1
(de)
|
2000-07-27 |
2009-01-15 |
Genentech Inc |
Sequentielle verabreichung von cpt-11 und apo-2l polypeptid
|
US20030228309A1
(en)
*
|
2000-11-08 |
2003-12-11 |
Theodora Salcedo |
Antibodies that immunospecifically bind to TRAIL receptors
|
CA2426710A1
(en)
*
|
2000-11-08 |
2002-10-10 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US20060062786A1
(en)
*
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20020155109A1
(en)
*
|
2001-04-20 |
2002-10-24 |
Lynch David H. |
Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2
|
US7115717B2
(en)
*
|
2001-05-18 |
2006-10-03 |
Kirin Beer Kabushiki Kaisha |
Anti-TRAIL-R antibodies
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
WO2002097033A2
(en)
|
2001-05-25 |
2002-12-05 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US20050214209A1
(en)
*
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US20050129616A1
(en)
*
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
US7361341B2
(en)
*
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
US20090226429A1
(en)
*
|
2001-05-25 |
2009-09-10 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
DK1409544T3
(da)
|
2001-07-03 |
2009-10-26 |
Genentech Inc |
Humane DR4-antistoffer og anvendelser deraf
|
WO2003013584A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Genset S.A. |
Xafinix agonists and antagonists for use in the treatment of metabolic disorders
|
ES2357225T3
(es)
*
|
2001-11-01 |
2011-04-20 |
Uab Research Foundation |
Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos.
|
US7842668B1
(en)
|
2001-11-13 |
2010-11-30 |
Genentech, Inc. |
Apo-2 ligand/trail formulations
|
US7741285B2
(en)
|
2001-11-13 |
2010-06-22 |
Genentech, Inc. |
APO-2 ligand/trail formulations
|
PT1450847E
(pt)
|
2001-11-13 |
2011-01-05 |
Genentech Inc |
Formulações de ligando de apo2/trail e suas utilizações
|
JP2005516958A
(ja)
*
|
2001-12-20 |
2005-06-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
Trailレセプターに免疫特異的に結合する抗体
|
ES2545090T3
(es)
|
2001-12-21 |
2015-09-08 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina y GCSF
|
WO2003104395A2
(en)
*
|
2002-05-22 |
2003-12-18 |
Incyte Corporation |
Receptors and membrane-associated proteins
|
JP4574350B2
(ja)
|
2002-06-24 |
2010-11-04 |
ジェネンテック, インコーポレイテッド |
Apo−2リガンド/trail変異体とその使用法
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
DE202004021950U1
(de)
|
2003-09-12 |
2013-06-19 |
Vessix Vascular, Inc. |
Auswählbare exzentrische Remodellierung und/oder Ablation von atherosklerotischem Material
|
EP1694841A2
(en)
*
|
2003-11-26 |
2006-08-30 |
The Queens University of Belfast |
Cancer treatment
|
US7892539B2
(en)
*
|
2004-03-24 |
2011-02-22 |
The Regents Of The University Of California |
Modulation of an innate immune response by altering TRIAL-R signaling
|
US20080260763A1
(en)
*
|
2004-07-01 |
2008-10-23 |
The Regents Of The University Of California |
High Throughput Proteomics
|
JP5237638B2
(ja)
|
2004-08-06 |
2013-07-17 |
ジェネンテック, インコーポレイテッド |
バイオマーカーを用いたアッセイおよび方法
|
ATE508753T1
(de)
|
2004-08-06 |
2011-05-15 |
Genentech Inc |
Assays und verfahren unter verwendung von biomarkern
|
EP1791864A2
(en)
*
|
2004-09-08 |
2007-06-06 |
Genentech, Inc. |
Methods of using death receptor ligands and cd20 antibodies
|
CN101048428A
(zh)
*
|
2004-09-08 |
2007-10-03 |
健泰科生物技术公司 |
利用死亡受体配体和cd20抗体的方法
|
US8396548B2
(en)
|
2008-11-14 |
2013-03-12 |
Vessix Vascular, Inc. |
Selective drug delivery in a lumen
|
US9713730B2
(en)
|
2004-09-10 |
2017-07-25 |
Boston Scientific Scimed, Inc. |
Apparatus and method for treatment of in-stent restenosis
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
US8129124B2
(en)
*
|
2005-02-02 |
2012-03-06 |
The Uab Research Foundation |
Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
US20090155247A1
(en)
*
|
2005-02-18 |
2009-06-18 |
Ashkenazi Avi J |
Methods of Using Death Receptor Agonists and EGFR Inhibitors
|
EP1915625B1
(en)
|
2005-08-16 |
2012-01-04 |
Genentech, Inc. |
Apoptosis sensitivity to apo2l/trail by testing for galnac-t14 expression in cells/tissues
|
US20070048325A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Dennis Van Epps |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
PE20071101A1
(es)
*
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
CA2626082C
(en)
|
2005-10-13 |
2017-04-11 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
CA2629306A1
(en)
|
2005-11-23 |
2007-05-31 |
Genentech, Inc. |
Methods and compositions related to b cell assays
|
US8019435B2
(en)
|
2006-05-02 |
2011-09-13 |
Boston Scientific Scimed, Inc. |
Control of arterial smooth muscle tone
|
EP2076198A4
(en)
|
2006-10-18 |
2009-12-09 |
Minnow Medical Inc |
Inducing Desired Temperatreating Effects on Body Weave
|
AU2007310988B2
(en)
|
2006-10-18 |
2013-08-15 |
Vessix Vascular, Inc. |
Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
|
EP3257462B1
(en)
|
2006-10-18 |
2022-12-21 |
Vessix Vascular, Inc. |
System for inducing desirable temperature effects on body tissue
|
CA2668100C
(en)
*
|
2006-11-01 |
2014-12-23 |
Immport Therapeutics, Inc. |
Compositions and methods for immunodominant antigens
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
KR20110009095A
(ko)
|
2008-03-03 |
2011-01-27 |
더 유니버시티 오브 마이애미 |
동종 이계 암 세포-기반 면역 요법
|
BRPI0919113A2
(pt)
|
2008-09-26 |
2016-08-09 |
Tocagen Inc |
polinucleotídeo isolado, polipeptídeo substancialmente purificado, vetor, célula hospedeira, retrovírus competente de reaplicação recombinante, e, métodos para tratar um indivíduo com um distúrbio de célula proliferativa, e para tratar um distúrbios de célula proliferativa em um indivíduo
|
EP2379585A2
(en)
|
2008-10-10 |
2011-10-26 |
Anaphore, Inc. |
Polypeptides that bind trail-ri and trail-r2
|
AU2009314133B2
(en)
|
2008-11-17 |
2015-12-10 |
Vessix Vascular, Inc. |
Selective accumulation of energy with or without knowledge of tissue topography
|
ES2738700T3
(es)
|
2009-02-13 |
2020-01-24 |
Immunomedics Inc |
Inmunoconjugados con un enlace escindible intracelularmente
|
WO2011034660A1
(en)
|
2009-09-16 |
2011-03-24 |
Immunomedics, Inc. |
Class i anti-cea antibodies and uses thereof
|
JP2013507124A
(ja)
*
|
2009-10-09 |
2013-03-04 |
アナフォア インコーポレイテッド |
Il−23rを結合するポリペプチド
|
KR20120101050A
(ko)
|
2009-11-05 |
2012-09-12 |
더 유에이비 리서치 파운데이션 |
기저형 유전자형 암의 치료 방법
|
CA2782194C
(en)
|
2009-12-02 |
2018-01-16 |
Immunomedics, Inc. |
Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer
|
US8703712B2
(en)
|
2010-03-18 |
2014-04-22 |
The Uab Research Foundation |
Targeting cancer stem cells with DR5 agonists
|
CN103068330B
(zh)
|
2010-04-09 |
2016-06-29 |
Vessix血管股份有限公司 |
用于治疗组织的功率发生和控制装置
|
US9192790B2
(en)
|
2010-04-14 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Focused ultrasonic renal denervation
|
WO2011143614A1
(en)
|
2010-05-14 |
2011-11-17 |
Amgen Inc. |
Enhanced death receptor agonists
|
US8473067B2
(en)
|
2010-06-11 |
2013-06-25 |
Boston Scientific Scimed, Inc. |
Renal denervation and stimulation employing wireless vascular energy transfer arrangement
|
WO2011159928A2
(en)
*
|
2010-06-16 |
2011-12-22 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Anti-dr4 agonist antibodies
|
US9463062B2
(en)
|
2010-07-30 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Cooled conductive balloon RF catheter for renal nerve ablation
|
US9084609B2
(en)
|
2010-07-30 |
2015-07-21 |
Boston Scientific Scime, Inc. |
Spiral balloon catheter for renal nerve ablation
|
US9358365B2
(en)
|
2010-07-30 |
2016-06-07 |
Boston Scientific Scimed, Inc. |
Precision electrode movement control for renal nerve ablation
|
US9408661B2
(en)
|
2010-07-30 |
2016-08-09 |
Patrick A. Haverkost |
RF electrodes on multiple flexible wires for renal nerve ablation
|
US9155589B2
(en)
|
2010-07-30 |
2015-10-13 |
Boston Scientific Scimed, Inc. |
Sequential activation RF electrode set for renal nerve ablation
|
US9677042B2
(en)
|
2010-10-08 |
2017-06-13 |
Terumo Bct, Inc. |
Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
US8974451B2
(en)
|
2010-10-25 |
2015-03-10 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation using conductive fluid jet and RF energy
|
US9220558B2
(en)
|
2010-10-27 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
RF renal denervation catheter with multiple independent electrodes
|
US9028485B2
(en)
|
2010-11-15 |
2015-05-12 |
Boston Scientific Scimed, Inc. |
Self-expanding cooling electrode for renal nerve ablation
|
US9089350B2
(en)
|
2010-11-16 |
2015-07-28 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
|
US9668811B2
(en)
|
2010-11-16 |
2017-06-06 |
Boston Scientific Scimed, Inc. |
Minimally invasive access for renal nerve ablation
|
US9326751B2
(en)
|
2010-11-17 |
2016-05-03 |
Boston Scientific Scimed, Inc. |
Catheter guidance of external energy for renal denervation
|
US9060761B2
(en)
|
2010-11-18 |
2015-06-23 |
Boston Scientific Scime, Inc. |
Catheter-focused magnetic field induced renal nerve ablation
|
EA029419B1
(ru)
|
2010-11-19 |
2018-03-30 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Нейтрализующие антитела против ccl20
|
US9023034B2
(en)
|
2010-11-22 |
2015-05-05 |
Boston Scientific Scimed, Inc. |
Renal ablation electrode with force-activatable conduction apparatus
|
US9192435B2
(en)
|
2010-11-22 |
2015-11-24 |
Boston Scientific Scimed, Inc. |
Renal denervation catheter with cooled RF electrode
|
US20120157993A1
(en)
|
2010-12-15 |
2012-06-21 |
Jenson Mark L |
Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
|
US9220561B2
(en)
|
2011-01-19 |
2015-12-29 |
Boston Scientific Scimed, Inc. |
Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
|
CA2828405A1
(en)
|
2011-02-28 |
2012-09-07 |
Istituto Di Ricovero E Cura A Carattere Scientifico Materno-Infantile Bu Rlo Garofolo - Ospedale Di Alta Specializzazione E Di Rilievo Nazionale |
Apoptosis-inducing molecules and uses therefor
|
WO2012151199A1
(en)
|
2011-05-02 |
2012-11-08 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
MX2013012716A
(es)
|
2011-05-03 |
2014-03-21 |
Genentech Inc |
Agentes de disociacion vascular y sus usos.
|
CN103813745B
(zh)
|
2011-07-20 |
2016-06-29 |
波士顿科学西美德公司 |
用以可视化、对准和消融神经的经皮装置及方法
|
AU2012287189B2
(en)
|
2011-07-22 |
2016-10-06 |
Boston Scientific Scimed, Inc. |
Nerve modulation system with a nerve modulation element positionable in a helical guide
|
WO2013055826A1
(en)
|
2011-10-10 |
2013-04-18 |
Boston Scientific Scimed, Inc. |
Medical devices including ablation electrodes
|
WO2013055815A1
(en)
|
2011-10-11 |
2013-04-18 |
Boston Scientific Scimed, Inc. |
Off -wall electrode device for nerve modulation
|
US9420955B2
(en)
|
2011-10-11 |
2016-08-23 |
Boston Scientific Scimed, Inc. |
Intravascular temperature monitoring system and method
|
US9364284B2
(en)
|
2011-10-12 |
2016-06-14 |
Boston Scientific Scimed, Inc. |
Method of making an off-wall spacer cage
|
US9162046B2
(en)
|
2011-10-18 |
2015-10-20 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
EP2768568B1
(en)
|
2011-10-18 |
2020-05-06 |
Boston Scientific Scimed, Inc. |
Integrated crossing balloon catheter
|
EP3366250A1
(en)
|
2011-11-08 |
2018-08-29 |
Boston Scientific Scimed, Inc. |
Ostial renal nerve ablation
|
WO2013074813A1
(en)
|
2011-11-15 |
2013-05-23 |
Boston Scientific Scimed, Inc. |
Device and methods for renal nerve modulation monitoring
|
US9119632B2
(en)
|
2011-11-21 |
2015-09-01 |
Boston Scientific Scimed, Inc. |
Deflectable renal nerve ablation catheter
|
US9265969B2
(en)
|
2011-12-21 |
2016-02-23 |
Cardiac Pacemakers, Inc. |
Methods for modulating cell function
|
WO2013096913A2
(en)
|
2011-12-23 |
2013-06-27 |
Vessix Vascular, Inc. |
Methods and apparatuses for remodeling tissue of or adjacent to a body passage
|
US9433760B2
(en)
|
2011-12-28 |
2016-09-06 |
Boston Scientific Scimed, Inc. |
Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
|
US9050106B2
(en)
|
2011-12-29 |
2015-06-09 |
Boston Scientific Scimed, Inc. |
Off-wall electrode device and methods for nerve modulation
|
MX350202B
(es)
|
2012-03-28 |
2017-08-30 |
Amgen Inc |
Combinaciones de agonistas de receptores de muerte 5 (dr5).
|
US10660703B2
(en)
|
2012-05-08 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices
|
EP2684896A1
(en)
|
2012-07-09 |
2014-01-15 |
International-Drug-Development-Biotech |
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof
|
WO2014028560A2
(en)
|
2012-08-14 |
2014-02-20 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
US10321946B2
(en)
|
2012-08-24 |
2019-06-18 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices with weeping RF ablation balloons
|
EP2895095A2
(en)
|
2012-09-17 |
2015-07-22 |
Boston Scientific Scimed, Inc. |
Self-positioning electrode system and method for renal nerve modulation
|
WO2014047454A2
(en)
|
2012-09-21 |
2014-03-27 |
Boston Scientific Scimed, Inc. |
Self-cooling ultrasound ablation catheter
|
US10398464B2
(en)
|
2012-09-21 |
2019-09-03 |
Boston Scientific Scimed, Inc. |
System for nerve modulation and innocuous thermal gradient nerve block
|
EP2906135A2
(en)
|
2012-10-10 |
2015-08-19 |
Boston Scientific Scimed, Inc. |
Renal nerve modulation devices and methods
|
ES2786051T3
(es)
|
2012-10-25 |
2020-10-08 |
Tocagen Inc |
Vector retroviral con casete de mini-promotor
|
HRP20220399T1
(hr)
|
2012-12-13 |
2022-05-13 |
Immunomedics, Inc. |
Režim doziranja imunokonjugata protutijela i sn-38 za poboljšanu učinkovitost i smanjenu toksičnost
|
WO2014163987A1
(en)
|
2013-03-11 |
2014-10-09 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9693821B2
(en)
|
2013-03-11 |
2017-07-04 |
Boston Scientific Scimed, Inc. |
Medical devices for modulating nerves
|
US9808311B2
(en)
|
2013-03-13 |
2017-11-07 |
Boston Scientific Scimed, Inc. |
Deflectable medical devices
|
PL2970473T3
(pl)
|
2013-03-14 |
2018-01-31 |
Bristol Myers Squibb Co |
Kombinacja agonisty dr5 i antagonisty anty-pd-1 oraz metody stosowania
|
JP6139772B2
(ja)
|
2013-03-15 |
2017-05-31 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
電極パッドと共に使用するための制御ユニットおよび漏電を推定するための方法
|
JP6220044B2
(ja)
|
2013-03-15 |
2017-10-25 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
腎神経アブレーションのための医療用デバイス
|
US10265122B2
(en)
|
2013-03-15 |
2019-04-23 |
Boston Scientific Scimed, Inc. |
Nerve ablation devices and related methods of use
|
US9943365B2
(en)
|
2013-06-21 |
2018-04-17 |
Boston Scientific Scimed, Inc. |
Renal denervation balloon catheter with ride along electrode support
|
EP3010436A1
(en)
|
2013-06-21 |
2016-04-27 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation having rotatable shafts
|
US9707036B2
(en)
|
2013-06-25 |
2017-07-18 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation using localized indifferent electrodes
|
WO2015002787A1
(en)
|
2013-07-01 |
2015-01-08 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
EP3019106A1
(en)
|
2013-07-11 |
2016-05-18 |
Boston Scientific Scimed, Inc. |
Medical device with stretchable electrode assemblies
|
US10660698B2
(en)
|
2013-07-11 |
2020-05-26 |
Boston Scientific Scimed, Inc. |
Devices and methods for nerve modulation
|
WO2015010074A1
(en)
|
2013-07-19 |
2015-01-22 |
Boston Scientific Scimed, Inc. |
Spiral bipolar electrode renal denervation balloon
|
US10342609B2
(en)
|
2013-07-22 |
2019-07-09 |
Boston Scientific Scimed, Inc. |
Medical devices for renal nerve ablation
|
US10695124B2
(en)
|
2013-07-22 |
2020-06-30 |
Boston Scientific Scimed, Inc. |
Renal nerve ablation catheter having twist balloon
|
JP6159888B2
(ja)
|
2013-08-22 |
2017-07-05 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
腎神経変調バルーンへの接着性を向上させたフレキシブル回路
|
WO2015035047A1
(en)
|
2013-09-04 |
2015-03-12 |
Boston Scientific Scimed, Inc. |
Radio frequency (rf) balloon catheter having flushing and cooling capability
|
EP3043733A1
(en)
|
2013-09-13 |
2016-07-20 |
Boston Scientific Scimed, Inc. |
Ablation balloon with vapor deposited cover layer
|
WO2015057521A1
(en)
|
2013-10-14 |
2015-04-23 |
Boston Scientific Scimed, Inc. |
High resolution cardiac mapping electrode array catheter
|
US11246654B2
(en)
|
2013-10-14 |
2022-02-15 |
Boston Scientific Scimed, Inc. |
Flexible renal nerve ablation devices and related methods of use and manufacture
|
US9770606B2
(en)
|
2013-10-15 |
2017-09-26 |
Boston Scientific Scimed, Inc. |
Ultrasound ablation catheter with cooling infusion and centering basket
|
EP3057520A1
(en)
|
2013-10-15 |
2016-08-24 |
Boston Scientific Scimed, Inc. |
Medical device balloon
|
WO2015057961A1
(en)
|
2013-10-18 |
2015-04-23 |
Boston Scientific Scimed, Inc. |
Balloon catheters with flexible conducting wires and related methods of use and manufacture
|
US10271898B2
(en)
|
2013-10-25 |
2019-04-30 |
Boston Scientific Scimed, Inc. |
Embedded thermocouple in denervation flex circuit
|
WO2015073913A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
EP3091922B1
(en)
|
2014-01-06 |
2018-10-17 |
Boston Scientific Scimed, Inc. |
Tear resistant flex circuit assembly
|
WO2015108046A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
WO2015119890A1
(en)
|
2014-02-04 |
2015-08-13 |
Boston Scientific Scimed, Inc. |
Alternative placement of thermal sensors on bipolar electrode
|
US11000679B2
(en)
|
2014-02-04 |
2021-05-11 |
Boston Scientific Scimed, Inc. |
Balloon protection and rewrapping devices and related methods of use
|
WO2015126548A1
(en)
|
2014-02-21 |
2015-08-27 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to trop-2 expressing cells
|
CA2935748A1
(en)
|
2014-02-25 |
2015-09-03 |
Immunomedics, Inc. |
Humanized rfb4 anti-cd22 antibody
|
US11299528B2
(en)
|
2014-03-11 |
2022-04-12 |
D&D Pharmatech Inc. |
Long acting TRAIL receptor agonists for treatment of autoimmune diseases
|
JP6783143B2
(ja)
|
2014-03-25 |
2020-11-11 |
テルモ ビーシーティー、インコーポレーテッド |
培地の受動的補充
|
WO2015200260A1
(en)
|
2014-06-24 |
2015-12-30 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
WO2016049421A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled feed
|
CA2961774C
(en)
|
2014-10-07 |
2023-05-23 |
Immunomedics, Inc. |
Neoadjuvant use of antibody-drug conjugates
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
CN114796501A
(zh)
|
2015-06-25 |
2022-07-29 |
免疫医疗公司 |
抗体与治疗剂的组合治疗癌症的方法
|
EP3316885B1
(en)
|
2015-07-01 |
2021-06-23 |
Immunomedics, Inc. |
Antibody-sn-38 immunoconjugates with a cl2a linker
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
MX2018006333A
(es)
|
2015-12-01 |
2018-08-01 |
Genmab Bv |
Anticuerpos anti-receptor de muerte 5 (dr5) y metodos de uso de los mismos.
|
US11007251B2
(en)
|
2015-12-17 |
2021-05-18 |
The Johns Hopkins University |
Ameliorating systemic sclerosis with death receptor agonists
|
JP7281795B2
(ja)
|
2016-04-07 |
2023-05-26 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
膵炎および疼痛をデス受容体アゴニストで処置するための組成物および方法
|
US11965175B2
(en)
|
2016-05-25 |
2024-04-23 |
Terumo Bct, Inc. |
Cell expansion
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
CN106243215B
(zh)
*
|
2016-08-17 |
2019-09-03 |
哈尔滨医科大学 |
一种人trail i型受体激动性抗原表位多肽及其抗体和应用
|
EP3323428A1
(en)
|
2016-11-17 |
2018-05-23 |
CNRS Centre National de la Recherche Scientifique |
Selective c-flip inhibitors as anticancer agents
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
JP7393945B2
(ja)
|
2017-03-31 |
2023-12-07 |
テルモ ビーシーティー、インコーポレーテッド |
細胞増殖
|
EP3910331A1
(en)
|
2020-05-15 |
2021-11-17 |
iOmx Therapeutics AG |
Intracellular kinase associated with resistance against t-cell mediated cytotoxicity, and uses thereof
|
US11767353B2
(en)
|
2020-06-05 |
2023-09-26 |
Theraly Fibrosis, Inc. |
Trail compositions with reduced immunogenicity
|
US12043823B2
(en)
|
2021-03-23 |
2024-07-23 |
Terumo Bct, Inc. |
Cell capture and expansion
|
EP4342497A1
(en)
|
2021-05-10 |
2024-03-27 |
Kawasaki Institute of Industrial Promotion |
Antibody having reduced binding affinity for antigen
|
EP4257132A1
(en)
|
2022-04-08 |
2023-10-11 |
iOmx Therapeutics AG |
Sik3 inhibitors for treating diseases resistant to death receptor signalling
|
WO2024175554A1
(en)
|
2023-02-21 |
2024-08-29 |
Institut Curie |
Trail agonists for use in the treatment of cancer in patients having an activating alteration of fgfr3
|